The signal begins when DNA damage activates phosphatidylinositol 3-kinase-related kinases, which phosphorylate histone H2AX at serine 139. This modified form, γH2AX, accumulates around the affected chromatin, creating a localized molecular mark that antibodies can detect. The phosphorylation step connects damage-associated signaling with the visible staining pattern used for analysis.
Nuclear foci provide a spatial readout rather than only a bulk indication of cellular stress. Because γH2AX accumulates around damaged chromatin, researchers can examine these localized signals in individual nuclei or tissue regions. Measuring the foci supports comparisons of DNA damage among experimental conditions, including cells exposed to radiation or chemotherapy.
Patterns of γH2AX foci can help compare how tumor cells respond to DNA-damaging treatments and how their repair responses differ. The method does not simply record that treatment occurred; it provides a staining-based damage readout that can be examined across conditions. In cancer research, this supports evaluation of treatment-associated genomic damage and response patterns.
The two antibody-based formats support related γH2AX measurements but suit different sample contexts. Immunofluorescence is used to visualize foci in cells, whereas immunohistochemistry supports analysis of tissue samples. Selecting between them allows investigators to match the detection approach to the material being studied while retaining the same damage-associated marker.
A basic γH2AX staining workflow begins with a cell or tissue sample and uses antibody-based immunofluorescence or immunohistochemistry to detect the phosphorylated marker. Researchers then examine or measure the resulting nuclear foci. Applying the same readout across experimental conditions allows comparisons of treatment-associated DNA damage, repair responses, or genotoxic effects.
In cancer research, γH2AX staining can assess how tumor cells respond to radiation or chemotherapy and compare their repair responses across experimental conditions. It also supports investigation of genotoxic effects, meaning damage to genetic material, and treatment-associated genomic damage. Together, these uses connect a molecular staining readout with cancer-treatment research questions.